We found that SCGB3A2 exhibits a potent anti-tumorigenic effect in some cancer types, especially non-small-cell lung cancers (NSCLCs) and epithelial-derived colorectal cancers. This evidence concerns the gene SCGB3A2 and colorectal cancer.